Michael L LaCroix-Fralish 1 , Gary Mo , Shad B Smith , Susana G Sotocinal , Jennifer Ritchie , Jean-Sebastien Austin , Kara Melmed , Ara Schorscher-Petcu , Audrey C Laferriere , Tae Hoon Lee , Dmitry Romanovsky , Guochun Liao , Mark A Behlke , David J Clark , Gary Peltz , Philippe Séguéla , Maxim Dobretsov , Jeffrey S Mogil
It is widely appreciated that there is significant inter-individual variability in pain sensitivity, yet only a handful of contributing genetic variants have been identified. Computational genetic mapping and quantitative trait locus analysis suggested that variation within the gene coding for the beta3 subunit of the Na+,K+-ATPase pump (Atp1b3) contributes to inter-strain differences in the early phase formalin pain behavior. Significant strain differences in Atp1b3 gene expression, beta3 protein expression, and biophysical properties of the Na+,K+ pump in dorsal root ganglia neurons from resistant (A/J) and sensitive (C57BL/6J) mouse strains supported the genetic prediction. Furthermore, in vivo siRNA knockdown of the beta3 subunit produced strain-specific changes in the early phase pain response, completely rescuing the strain difference. These findings indicate that the beta3 subunit of the Na+,K+-ATPase is a novel determinant of nociceptive sensitivity and further supports the notion that pain variability genes can have very selective effects on individual pain modalities.